These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8931848)

  • 1. Orthostatic hypotension: how to avoid it during antihypertensive therapy.
    Rieckert H
    Am J Hypertens; 1996 Nov; 9(11):155S-159S. PubMed ID: 8931848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic properties and therapeutic use of bunazosin in hypertension. A review.
    Weidinger G
    Arzneimittelforschung; 1995 Nov; 45(11):1166-71. PubMed ID: 8929232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive efficacy and orthostatic tolerance of bunazosin vs nitrendipine: a multicentre double-blind randomized controlled study.
    Langenfeld MR; Bräutigam M; Weidinger G; Assmann I; Krönig B; Schmieder RE
    J Hum Hypertens; 1996 Dec; 10(12):831-6. PubMed ID: 9140791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of essential hypertension with the alpha-1 antagonist bunazosin retard. A multicenter, double-blind, placebo-controlled study].
    Kirsten R; Weidinger G
    Arzneimittelforschung; 1994 Jan; 44(1):13-6. PubMed ID: 7907871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal haemodynamic effects of bunazosin retard and prazosin in mild to moderately hypertensive patients with normal or moderately impaired renal function.
    Anderton JL; Gill M; Notghi A
    Nephrol Dial Transplant; 1994; 9(6):607-12. PubMed ID: 7970085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthostatic hypotension after the first administration of prazosin in hypertensive patients: role of the plasma volume.
    Semplicini A; Pessina AC; Palatini P; Hlede M; Palù CD
    Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):1-10. PubMed ID: 6162595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The hypotensive effect of prazosin].
    Huysmans FT; Thien T; Rosier JG; van't Laar A; Koene RA
    Ned Tijdschr Geneeskd; 1980 Jul; 124(28):1141-7. PubMed ID: 7402391
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients.
    Eriksson JW; Jansson PA; Foley K; Lithell H
    J Hypertens; 1996 Dec; 14(12):1469-75. PubMed ID: 8986932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Within patient comparison of prazosin and UK-33,274. A new alpha-adrenoceptor-antagonist.
    de Leeuw PW; Ligthart JJ; Smout AJ; Birkenhäger WH
    Eur J Clin Pharmacol; 1982; 23(5):397-401. PubMed ID: 6129979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of alpha-blockers in the management of hypertension: a practical view.
    McInnes GT
    J Hum Hypertens; 1991 Aug; 5(4):313-6. PubMed ID: 1683406
    [No Abstract]   [Full Text] [Related]  

  • 11. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
    Deger G
    Am J Med; 1986 May; 80(5B):62-7. PubMed ID: 2872809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral and intravenous terazosin and head-up tilt on blood pressure responses in patients with hypertension.
    Achari R; Hosmane B; Linnen P; Cavanaugh J; Baroldi P; Cohen A
    J Clin Pharmacol; 1998 Jun; 38(6):545-53. PubMed ID: 9650545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial and long-term effects of prazosin on sympathetic vasopressor responses in essential hypertension.
    Khatri IM; Levinson P; Notargiacomo A; Freis ED
    Am J Cardiol; 1985 Apr; 55(8):1015-8. PubMed ID: 3984860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive monotherapy with prazosin].
    Liebau G; Baetzner P; Futter G; Hayduk K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():308-11. PubMed ID: 347803
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension.
    Nechwatal W; Berger J; Blumrich W; Bouzo H; Brandl K; Braun S; Laukaitis A; Müller G; Ryba W; Schreiegg J
    Am Heart J; 1988 Dec; 116(6 Pt 2):1806-14. PubMed ID: 2904755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-phase clinical evaluation of prazosin.
    Smith IS; Fernandes M; Kim KE; Swartz C; Onesti G
    Postgrad Med; 1975 Nov; Spec No():53-60. PubMed ID: 1105485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antihypertensive and endocrinologic effects of clonidine and prazosin in patients with essential hypertension.
    Hubbell FA; Weber MA; Drayer JI; Rose DE
    South Med J; 1984 Oct; 77(10):1264-8. PubMed ID: 6385278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension.
    Sega R; Marazzi ME; Bombelli M; Vulpis V; Antonacci A; Leto di Priolo S; Pirrelli A; Libretti A
    Pharmacol Res; 1991 Jul; 24(1):41-52. PubMed ID: 1682905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prazosin in hypertension. Part II. Effects of the initial dose.
    Turner AS; Watson OF; Brocklehurst JE
    N Z Med J; 1977 Sep; 86(596):286-9. PubMed ID: 343006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.